Dysregulation of de novo lipogenesis (DNL) has recently gained strong attention as being one of the critical factors that contribute to the assessment of
non-alcoholic fatty liver disease (
NAFLD).
NAFLD is often diagnosed in patients with
dyslipidemias and
type 2 diabetes; thus, an interesting correlation can be deduced between high hematic
free fatty acids and
glucose excess in the DNL dysregulation. In the present study, we report that, in a cellular model of
NAFLD, the coexistence of elevated
glucose and FFA conditions caused the highest cellular
lipid accumulation. Deepening the molecular mechanisms of the DNL dysregulation-RT-qPCR and immunoblot analysis demonstrated increased expression of mitochondrial
citrate carrier (CiC), cytosolic
acetyl-CoA carboxylase 1 (ACACA), and
diacylglycerol acyltransferase 2 (DGAT2) involved in
fatty acids and
triglycerides synthesis, respectively. XBP-1, an endoplasmic reticulum stress marker, and SREBP-1 were the
transcription factors connected to the DNL activation.
Quercetin (Que), a
flavonoid with strong
antioxidant properties, and noticeably reduced the
lipid accumulation and the expression of SREBP-1 and XBP-1, as well as of their lipogenic gene targets in steatotic cells. The anti-lipogenic action of Que mainly occurs through a strong phosphorylation of ACACA, which catalyzes the committing step in the DNL pathway. The high level of ACACA phosphorylation in Que-treated cells was explained by the intervention of AMPK together with the reduction of enzymatic activity of PP2A
phosphatase. Overall, our findings highlight a direct anti-lipogenic effect of Que exerted through inhibition of the DNL pathway by acting on ACACA/AMPK/PP2A axis; thus, suggesting this
flavonoid as a promising molecule for the
NAFLD treatment.